XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.5581
-0.0233 (-4.01%)
At close: Nov 7, 2025, 4:00 PM EST
0.5488
-0.0093 (-1.67%)
After-hours: Nov 7, 2025, 6:44 PM EST
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of $3.21 million as of November 7, 2025. Its market cap has decreased by -44.39% in one year.
Market Cap
3.21M
Enterprise Value
2.25M
1-Year Change
-44.39%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since January 11, 2018, XORTX Therapeutics's market cap has decreased from $25.10M to $3.21M, a decrease of -87.22%. That is a compound annual growth rate of -23.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 3.21M | -21.57% |
| Dec 30, 2024 | 4.09M | -6.85% |
| Dec 29, 2023 | 4.39M | -63.14% |
| Dec 30, 2022 | 11.91M | -53.60% |
| Dec 31, 2021 | 25.66M | 177.78% |
| Dec 31, 2020 | 9.24M | 19.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |